Biotechnology
The Biotechnology industry has a total of 586 stocks, with a combined market cap of $1.08 trillion and total revenue of $110 billion.
Market Cap
1.08T
Revenue
110B
Profits
-41.21B
PE Ratio
n/a
Profit Margin
-37.46%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.43B | -0.87% | 1,149,269 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.20B | -3.79% | 1,259,201 | 14.92B |
| 3 | ARGX | argenx SE | 54.81B | -1.00% | 484,365 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.01B | -3.59% | 1,651,371 | 4.29B |
| 5 | RPRX | Royalty Pharma plc | 31.59B | -1.81% | 3,714,639 | 2.44B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.57B | -0.50% | 2,734,779 | - |
| 7 | ONC | BeOne Medicines AG | 30.11B | 0.26% | 285,134 | 5.70B |
| 8 | BNTX | BioNTech SE | 21.62B | -2.93% | 1,121,279 | 3.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.49B | -0.31% | 6,072,626 | 8.26M |
| 10 | INSM | Insmed Incorporated | 20.41B | -0.05% | 5,010,324 | 819.56M |
| 11 | INCY | Incyte Corporation | 20.11B | -1.70% | 2,975,172 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.89B | 0.34% | 3,994,249 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.27B | -1.39% | 1,435,020 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.56B | -2.74% | 1,208,493 | 4.44B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.20B | -0.35% | 1,737,569 | 579.96M |
| 16 | EXEL | Exelixis, Inc. | 13.01B | -1.82% | 1,918,093 | 2.38B |
| 17 | ASND | Ascendis Pharma A/S | 12.78B | -2.20% | 1,092,182 | 998.25M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.15B | -1.26% | 1,620,587 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.10B | 1.21% | 548,844 | 708.24M |
| 20 | SMMT | Summit Therapeutics Inc. | 10.95B | -4.47% | 5,493,014 | - |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.93B | -0.39% | 2,062,949 | 3.24B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.77B | -4.05% | 262,727 | 1.13B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.40B | 1.05% | 1,204,680 | 622.01M |
| 24 | CYTK | Cytokinetics, Incorporated | 9.22B | -5.01% | 2,382,329 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 8.90B | 0.25% | 259,661 | 417.30M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.39B | -1.12% | 1,496,609 | 1.51B |
| 27 | TECH | Bio-Techne Corporation | 8.24B | 1.27% | 4,439,998 | 1.21B |
| 28 | ABVX | ABIVAX Société Anonyme | 8.20B | - | 1,821,837 | 5.67M |
| 29 | CORT | Corcept Therapeutics Incorporated | 7.87B | 0.98% | 867,327 | 769.10M |
| 30 | IBRX | ImmunityBio, Inc. | 7.51B | 3.61% | 11,386,905 | 140.98M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.06B | -0.30% | 679,808 | 7.46M |
| 32 | NUVL | Nuvalent, Inc. | 6.99B | -2.70% | 1,074,668 | - |
| 33 | PCVX | Vaxcyte, Inc. | 6.69B | -2.17% | 1,341,175 | - |
| 34 | IMVT | Immunovant, Inc. | 6.32B | -1.00% | 1,015,535 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.30B | 0.67% | 567,714 | 74.06M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.25B | -2.24% | 1,035,946 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.22B | -4.50% | 1,304,571 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | 0.20% | 553,274 | 15.00M |
| 39 | KYMR | Kymera Therapeutics, Inc. | 6.08B | -0.24% | 453,688 | 51.48M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.89B | -0.55% | 483,151 | 217.17M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.88B | -0.14% | 1,293,284 | 827.11M |
| 42 | LEGN | Legend Biotech Corporation | 5.85B | -3.37% | 3,203,461 | 1.14B |
| 43 | TGTX | TG Therapeutics, Inc. | 5.80B | 1.97% | 1,555,840 | 700.35M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | 0.11% | 473,319 | 569.61M |
| 45 | BLTE | Belite Bio, Inc | 5.49B | -2.60% | 153,178 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.33B | 0.45% | 1,901,361 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.25B | -1.13% | 811,956 | - |
| 48 | CRSP | CRISPR Therapeutics AG | 4.98B | -0.46% | 1,131,312 | 4.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 4.95B | -1.01% | 1,180,969 | 7.50M |
| 50 | CGON | CG Oncology, Inc. | 4.80B | 1.27% | 828,325 | 5.07M |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 4.76B | 0.32% | 219,150 | 274.48M |
| 52 | CAI | Caris Life Sciences, Inc. | 4.56B | -2.12% | 3,402,995 | 907.29M |
| 53 | TNGX | Tango Therapeutics, Inc. | 4.47B | 52.97% | 21,825,741 | 56.99M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 0.88% | 559,562 | 1.34M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.38B | 2.77% | 1,943,769 | 536.20M |
| 56 | CELC | Celcuity Inc. | 4.26B | -0.96% | 1,437,721 | - |
| 57 | ERAS | Erasca, Inc. | 4.00B | 7.52% | 5,856,674 | - |
| 58 | ORKA | Oruka Therapeutics, Inc. | 3.86B | 6.52% | 1,086,603 | - |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.03% | 1,589,008 | 596.96M |
| 60 | MANE | Veradermics, Incorporated | 3.77B | -1.49% | 425,649 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 3.75B | -2.11% | 1,139,904 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 0.65% | 883,774 | 1.10B |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | -1.81% | 512,930 | 22.57M |
| 64 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.53B | 1.70% | 993,833 | 18.07M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.39B | 2.78% | 2,096,390 | - |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.19B | -0.81% | 98,897 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.10B | 0.10% | 1,893,414 | - |
| 68 | RLAY | Relay Therapeutics, Inc. | 2.98B | 1.04% | 2,908,199 | 10.68M |
| 69 | BEAM | Beam Therapeutics Inc. | 2.96B | 1.29% | 1,311,629 | 164.01M |
| 70 | RCUS | Arcus Biosciences, Inc. | 2.93B | 0.56% | 812,214 | 236.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.78B | -1.35% | 2,058,344 | - |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 2.77B | 11.28% | 2,580,752 | 225.27M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.69B | 1.46% | 1,120,752 | 415.62M |
| 74 | GPCR | Structure Therapeutics Inc. | 2.68B | 0.51% | 764,704 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 0.61% | 443,376 | 535.08M |
| 76 | KLRA | Kailera Therapeutics, Inc. | 2.55B | 1.70% | 722,560 | - |
| 77 | IRON | Disc Medicine, Inc. | 2.51B | -1.79% | 711,479 | - |
| 78 | DFTX | Definium Therapeutics, Inc. | 2.51B | -2.25% | 3,644,685 | - |
| 79 | ALMS | Alumis Inc. | 2.42B | -0.37% | 1,711,868 | 8.40M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.28B | -1.67% | 698,868 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.24B | -0.21% | 629,704 | 865.00K |
| 82 | PHVS | Pharvaris N.V. | 2.20B | 1.61% | 552,721 | - |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.12B | -1.46% | 1,689,266 | 670.00M |
| 84 | IMNM | Immunome, Inc. | 2.11B | 0.16% | 1,094,630 | 4.02M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.05B | -3.11% | 834,212 | - |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -1.14% | 783,617 | 298.30M |
| 87 | TRVI | Trevi Therapeutics, Inc. | 1.92B | 1.28% | 697,508 | - |
| 88 | NKTR | Nektar Therapeutics | 1.91B | -1.22% | 1,000,137 | 55.63M |
| 89 | NTLA | Intellia Therapeutics, Inc. | 1.88B | -0.37% | 3,420,275 | 66.09M |
| 90 | MESO | Mesoblast Limited | 1.88B | -1.08% | 181,580 | 65.38M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 1.88B | 0.67% | 479,726 | 899.11M |
| 92 | ADMA | ADMA Biologics, Inc. | 1.87B | 1.13% | 2,603,331 | 509.86M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 1.86B | -5.02% | 2,021,812 | - |
| 94 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -0.68% | 214,701 | 1.20B |
| 95 | ZLAB | Zai Lab Limited | 1.85B | -0.84% | 1,084,399 | 453.28M |
| 96 | KOD | Kodiak Sciences Inc. | 1.85B | -4.64% | 822,219 | - |
| 97 | VCEL | Vericel Corporation | 1.83B | -1.46% | 371,973 | 292.09M |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.81B | -3.37% | 331,442 | 32.08M |
| 99 | NBTX | Nanobiotix S.A. | 1.80B | 0.76% | 25,977 | 38.27M |
| 100 | OCUL | Ocular Therapeutix, Inc. | 1.79B | -1.09% | 1,502,296 | 52.04M |
| 101 | IOVA | Iovance Biotherapeutics, Inc. | 1.79B | -5.44% | 11,285,622 | 285.61M |
| 102 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 0.15% | 15,796,647 | 66.41M |
| 103 | RAPP | Rapport Therapeutics, Inc. | 1.75B | 1.61% | 151,244 | 20.00M |
| 104 | ZYME | Zymeworks Inc. | 1.75B | -0.46% | 553,167 | 81.26M |
| 105 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -0.32% | 1,096,875 | 70.92M |
| 106 | QURE | uniQure N.V. | 1.70B | 2.08% | 761,116 | 18.09M |
| 107 | BHVN | Biohaven Ltd. | 1.67B | 2.96% | 2,281,301 | - |
| 108 | NUVB | Nuvation Bio Inc. | 1.67B | -0.41% | 2,964,607 | 143.05M |
| 109 | ABCL | AbCellera Biologics Inc. | 1.65B | -3.56% | 4,784,974 | 79.21M |
| 110 | INVA | Innoviva, Inc. | 1.65B | -0.84% | 913,452 | 420.69M |
| 111 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | -1.27% | 2,425,796 | 2.18B |
| 112 | GENB | Generate Biomedicines, Inc. | 1.64B | -0.70% | 817,347 | 30.30M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | -2.97% | 520,708 | 66.05M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.62B | 6.83% | 21,065,182 | 71.78M |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.59B | 0.41% | 1,198,481 | - |
| 116 | AAPG | Ascentage Pharma Group International | 1.59B | -0.47% | 3,211 | 82.08M |
| 117 | FTRE | Fortrea Holdings Inc. | 1.57B | 3.05% | 1,186,698 | 2.71B |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -1.27% | 3,501,809 | 7.47M |
| 119 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -2.06% | 640,671 | 11.13M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.51B | -5.26% | 423,758 | - |
| 121 | PVLA | Palvella Therapeutics, Inc. | 1.51B | -3.15% | 368,318 | - |
| 122 | SNDX | Syndax Pharmaceuticals, Inc. | 1.50B | -2.19% | 2,338,407 | 217.17M |
| 123 | ANAB | AnaptysBio, Inc. | 1.49B | 1.97% | 384,539 | 232.39M |
| 124 | SLS | SELLAS Life Sciences Group, Inc. | 1.48B | -3.04% | 5,887,226 | - |
| 125 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | 0.15% | 1,844,273 | 114.48M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 3.85% | 2,046,148 | 42.95M |
| 127 | VIR | Vir Biotechnology, Inc. | 1.43B | -2.31% | 1,332,806 | 65.50M |
| 128 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 0.49% | 438,234 | - |
| 129 | NVAX | Novavax, Inc. | 1.42B | -9.17% | 6,864,237 | 596.34M |
| 130 | IMCR | Immunocore Holdings plc | 1.41B | -1.77% | 454,160 | 412.81M |
| 131 | ATAI | AtaiBeckley Inc. | 1.40B | -3.54% | 4,929,036 | 3.49M |
| 132 | GHRS | GH Research PLC | 1.38B | -6.11% | 379,047 | - |
| 133 | MBX | MBX Biosciences, Inc. | 1.38B | -4.23% | 739,110 | - |
| 134 | SEPN | Septerna, Inc. | 1.37B | -2.38% | 327,215 | 72.26M |
| 135 | ARDX | Ardelyx, Inc. | 1.37B | -0.36% | 1,817,292 | 427.68M |
| 136 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 5.18% | 235,071 | - |
| 137 | URGN | UroGen Pharma Ltd. | 1.33B | 1.49% | 671,594 | 140.49M |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.56% | 1,213,598 | - |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.32B | 0.50% | 478,295 | - |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.31B | 2.44% | 194,457 | 1.30M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.31B | -2.84% | 449,048 | 20.00M |
| 142 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.30B | 0.40% | 2,807,795 | 204.73M |
| 143 | DMRA | Damora Therapeutics, Inc. | 1.29B | -0.48% | 302,088 | - |
| 144 | SVRA | Savara Inc. | 1.28B | -0.59% | 920,545 | - |
| 145 | PGEN | Precigen, Inc. | 1.27B | -0.28% | 4,630,105 | 31.60M |
| 146 | IMTX | Immatics N.V. | 1.24B | -5.82% | 339,686 | 43.00M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.17B | 3.70% | 272,288 | - |
| 148 | COAG | Hemab Therapeutics Holdings, Inc. | 1.13B | 0.99% | 202,389 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.11B | 0.80% | 504,605 | 10.00M |
| 150 | WVE | Wave Life Sciences Ltd. | 1.10B | -0.52% | 3,340,637 | 71.80M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.05B | 0.53% | 155,614 | 8.28M |
| 152 | MNKD | MannKind Corporation | 1.05B | -0.29% | 2,349,399 | 360.78M |
| 153 | ABSI | Absci Corporation | 1.02B | 2.34% | 2,748,353 | 1.84M |
| 154 | DBVT | DBV Technologies S.A. | 970.44M | -3.56% | 178,466 | 5.74M |
| 155 | EYPT | EyePoint, Inc. | 959.98M | -2.80% | 805,677 | 7.61M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 937.61M | 0.27% | 915,307 | - |
| 157 | PHAR | Pharming Group N.V. | 906.06M | 2.07% | 9,399 | 369.49M |
| 158 | SPRY | ARS Pharmaceuticals, Inc. | 892.74M | 5.02% | 1,909,593 | 98.99M |
| 159 | JBIO | Jade Biosciences, Inc. | 889.21M | -11.57% | 1,466,299 | - |
| 160 | OLMA | Olema Pharmaceuticals, Inc. | 869.98M | -3.39% | 1,377,509 | - |
| 161 | SPTX | Seaport Therapeutics, Inc. | 859.05M | -1.46% | 109,683 | - |
| 162 | XNCR | Xencor, Inc. | 845.96M | -3.06% | 776,151 | 97.36M |
| 163 | LBRX | LB Pharmaceuticals Inc | 843.09M | 3.05% | 99,811 | - |
| 164 | MGTX | MeiraGTx Holdings plc | 841.82M | 1.00% | 479,171 | 79.76M |
| 165 | TBPH | Theravance Biopharma, Inc. | 839.80M | - | 227,071 | 109.78M |
| 166 | ANNX | Annexon, Inc. | 838.87M | -3.21% | 3,315,505 | - |
| 167 | ABUS | Arbutus Biopharma Corporation | 837.56M | -0.24% | 747,465 | 191.45M |
| 168 | DRTS | Alpha Tau Medical Ltd. | 836.83M | -0.75% | 598,282 | - |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 835.09M | -1.57% | 1,489,320 | 69.64M |
| 170 | JANX | Janux Therapeutics, Inc. | 823.90M | 1.12% | 639,910 | 13.73M |
| 171 | IVA | Inventiva S.A. | 819.08M | -2.98% | 313,966 | 7.94M |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 816.16M | -1.70% | 1,741,175 | - |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 807.62M | 4.20% | 197,785 | 2.98M |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 794.30M | -1.28% | 720,373 | 204.89M |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 779.49M | 0.40% | 1,762,025 | - |
| 176 | KURA | Kura Oncology, Inc. | 759.91M | -2.06% | 1,426,423 | 71.64M |
| 177 | SANA | Sana Biotechnology, Inc. | 748.60M | 0.37% | 3,344,197 | - |
| 178 | REPL | Replimune Group, Inc. | 740.68M | -5.28% | 3,142,785 | - |
| 179 | EVMN | Evommune, Inc. | 727.21M | 1.36% | 335,740 | 10.00M |
| 180 | GERN | Geron Corporation | 724.92M | -3.42% | 11,184,518 | 196.12M |
| 181 | VOR | Vor Biopharma Inc. | 720.13M | 0.99% | 871,173 | - |
| 182 | AURA | Aura Biosciences, Inc. | 714.74M | -2.26% | 248,432 | - |
| 183 | ZVRA | Zevra Therapeutics, Inc. | 714.70M | 13.95% | 3,529,016 | 122.29M |
| 184 | OMER | Omeros Corporation | 712.90M | 0.61% | 1,407,384 | 9.89M |
| 185 | CRMD | CorMedix Inc. | 669.98M | 2.15% | 1,822,336 | 400.05M |
| 186 | AVTX | Avalo Therapeutics, Inc. | 669.69M | -2.75% | 1,044,930 | 59.00K |
| 187 | DSGN | Design Therapeutics, Inc. | 653.30M | -1.78% | 700,056 | - |
| 188 | OCS | Oculis Holding AG | 646.76M | -4.46% | 1,468,523 | 1.40M |
| 189 | CTMX | CytomX Therapeutics, Inc. | 640.05M | -2.00% | 3,643,560 | 35.54M |
| 190 | ANRO | Alto Neuroscience, Inc. | 639.36M | -0.11% | 515,535 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 638.54M | -1.60% | 9,264,074 | 22.00K |
| 192 | SLDB | Solid Biosciences Inc. | 631.06M | -4.33% | 862,700 | - |
| 193 | DRUG | Bright Minds Biosciences Inc. | 629.81M | -5.39% | 352,609 | - |
| 194 | SGP | SpyGlass Pharma, Inc. | 625.75M | -0.32% | 77,196 | - |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 623.23M | -0.38% | 206,708 | - |
| 196 | CADL | Candel Therapeutics, Inc. | 622.80M | -0.12% | 1,508,846 | - |
| 197 | TENX | Tenax Therapeutics, Inc. | 620.58M | -1.77% | 588,061 | - |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 608.93M | - | 1,464,030 | 8.37M |
| 199 | RLMD | Relmada Therapeutics, Inc. | 599.97M | -3.87% | 1,575,384 | - |
| 200 | CBIO | Crescent Biopharma, Inc. | 574.20M | -4.00% | 238,263 | 11.88M |
| 201 | ACHV | Achieve Life Sciences, Inc. | 562.57M | 6.82% | 1,107,736 | - |
| 202 | RIGL | Rigel Pharmaceuticals, Inc. | 556.54M | 0.50% | 187,387 | 299.77M |
| 203 | GYRE | Gyre Therapeutics, Inc. | 552.80M | -3.82% | 76,626 | 117.05M |
| 204 | MDXG | MiMedx Group, Inc. | 551.10M | -1.07% | 1,088,762 | 389.42M |
| 205 | TRAX | First Tracks Biotherapeutics, Inc. | 549.56M | -5.12% | 674,557 | - |
| 206 | IMMX | Immix Biopharma, Inc. | 549.25M | -0.76% | 1,081,390 | - |
| 207 | TECX | Tectonic Therapeutic, Inc. | 549.09M | 0.34% | 84,400 | - |
| 208 | PRME | Prime Medicine, Inc. | 534.63M | -3.27% | 2,459,803 | 4.03M |
| 209 | ALT | Altimmune, Inc. | 530.91M | 0.74% | 2,172,837 | 36.00K |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.48M | -1.58% | 821,245 | 151.40M |
| 211 | XOMA | XOMA Royalty Corporation | 525.72M | -0.40% | 107,413 | 48.56M |
| 212 | CABA | Cabaletta Bio, Inc. | 521.78M | -1.54% | 2,977,573 | - |
| 213 | PROK | ProKidney Corp. | 516.52M | -5.00% | 998,725 | 889.00K |
| 214 | CLYM | Climb Bio, Inc. | 514.47M | 2.09% | 2,228,467 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 507.75M | 3.93% | 304,407 | - |
| 216 | VALN | Valneva SE | 506.31M | -2.65% | 22,376 | 180.25M |
| 217 | EIKN | Eikon Therapeutics, Inc. | 486.16M | 0.22% | 188,926 | - |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 466.69M | 3.15% | 651,585 | - |
| 219 | ARVN | Arvinas, Inc. | 461.33M | -3.64% | 692,610 | 89.40M |
| 220 | NGNE | Neurogene Inc. | 451.93M | 7.97% | 166,595 | 925.00K |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 451.67M | - | 565,074 | 88.24M |
| 222 | PRTA | Prothena Corporation plc | 448.14M | -2.62% | 313,207 | 57.94M |
| 223 | ASMB | Assembly Biosciences, Inc. | 446.98M | -1.51% | 153,127 | 71.10M |
| 224 | OVID | Ovid Therapeutics Inc. | 440.47M | -1.67% | 1,471,464 | 7.12M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 431.06M | 0.35% | 97,538 | - |
| 226 | OCGN | Ocugen, Inc. | 426.54M | -1.56% | 3,388,974 | 4.47M |
| 227 | RZLT | Rezolute, Inc. | 426.22M | -4.00% | 2,261,430 | - |
| 228 | STRO | Sutro Biopharma, Inc. | 421.05M | -2.61% | 169,879 | 99.61M |
| 229 | ANL | Adlai Nortye Ltd. | 409.20M | 2.81% | 165,567 | 5.00M |
| 230 | MNPR | Monopar Therapeutics Inc. | 406.01M | 1.90% | 78,242 | - |
| 231 | EDIT | Editas Medicine, Inc. | 405.91M | -2.40% | 1,477,585 | 38.69M |
| 232 | SGMT | Sagimet Biosciences Inc. | 403.24M | -3.40% | 621,592 | - |
| 233 | VTVT | vTv Therapeutics Inc. | 397.85M | -0.25% | 15,482 | 36.84M |
| 234 | CCCC | C4 Therapeutics, Inc. | 395.55M | -6.75% | 1,951,229 | 34.86M |
| 235 | EPRX | Eupraxia Pharmaceuticals Inc. | 392.90M | 0.67% | 312,184 | - |
| 236 | AUTL | Autolus Therapeutics plc | 388.57M | -4.58% | 1,536,772 | 92.62M |
| 237 | CNXU | Conexeu Sciences Inc. | 385.87M | 0.20% | 90,293 | - |
| 238 | FBRX | Forte Biosciences, Inc. | 382.91M | -5.15% | 248,923 | - |
| 239 | PRLD | Prelude Therapeutics Incorporated | 382.83M | 1.31% | 281,278 | 16.72M |
| 240 | IPSC | Century Therapeutics, Inc. | 382.35M | -0.47% | 578,917 | 109.16M |
| 241 | CMPX | Compass Therapeutics, Inc. | 363.78M | -0.98% | 2,267,969 | 850.00K |
| 242 | BNTC | Benitec Biopharma Inc. | 360.72M | -0.47% | 68,639 | - |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 357.21M | -1.49% | 786,580 | 217.78M |
| 244 | UPB | Upstream Bio, Inc. | 351.01M | -8.51% | 783,296 | 3.32M |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 349.93M | -3.13% | 451,721 | 9.01M |
| 246 | PBYI | Puma Biotechnology, Inc. | 349.17M | -2.42% | 141,162 | 227.18M |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 345.72M | 1.65% | 245,251 | - |
| 248 | ZURA | Zura Bio Limited | 334.93M | 3.82% | 655,386 | - |
| 249 | LXEO | Lexeo Therapeutics, Inc. | 330.58M | -3.66% | 501,851 | - |
| 250 | OABI | OmniAb, Inc. | 330.54M | -8.06% | 611,001 | 28.94M |
| 251 | ARTV | Artiva Biotherapeutics, Inc. | 330.40M | -0.73% | 586,301 | 251.00K |
| 252 | LRMR | Larimar Therapeutics, Inc. | 323.59M | -2.21% | 1,467,284 | - |
| 253 | VSTM | Verastem, Inc. | 322.50M | -1.08% | 1,866,569 | 49.59M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 321.90M | -1.86% | 158,110 | 69.21M |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 317.78M | -2.70% | 173,029 | - |
| 256 | RGNX | REGENXBIO Inc. | 316.91M | 0.82% | 1,198,038 | 87.82M |
| 257 | FENC | Fennec Pharmaceuticals Inc. | 309.16M | 2.30% | 321,355 | 51.00M |
| 258 | ABEO | Abeona Therapeutics Inc. | 306.63M | -1.47% | 706,920 | 14.54M |
| 259 | HUMA | Humacyte, Inc. | 306.39M | 2.22% | 3,780,539 | 2.02M |
| 260 | DMAC | DiaMedica Therapeutics Inc. | 302.29M | -0.53% | 156,242 | - |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 301.65M | 1.68% | 1,064,159 | 14.78M |
| 262 | IVVD | Invivyd, Inc. | 300.50M | -0.97% | 2,612,395 | 55.87M |
| 263 | STTK | Shattuck Labs, Inc. | 299.05M | -14.85% | 5,579,699 | 1.00M |
| 264 | NAUT | Nautilus Biotechnology, Inc. | 296.09M | -2.51% | 441,485 | - |
| 265 | NMRA | Neumora Therapeutics, Inc. | 295.95M | -0.61% | 600,977 | - |
| 266 | RCKT | Rocket Pharmaceuticals, Inc. | 294.82M | -1.82% | 2,360,807 | - |
| 267 | SLN | Silence Therapeutics plc | 294.27M | 0.97% | 77,400 | 839.00K |
| 268 | PALI | Palisade Bio, Inc. | 291.32M | - | 1,100,745 | - |
| 269 | IRD | Opus Genetics, Inc. | 287.75M | - | 536,218 | 11.98M |
| 270 | LYEL | Lyell Immunopharma, Inc. | 287.24M | 2.84% | 124,766 | 31.00K |
| 271 | BCYC | Bicycle Therapeutics plc | 286.92M | -2.14% | 259,460 | 63.50M |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 277.78M | 0.93% | 24,638 | 5.20M |
| 273 | ELDN | Eledon Pharmaceuticals, Inc. | 276.74M | 4.99% | 1,829,532 | - |
| 274 | IKT | Inhibikase Therapeutics, Inc. | 276.08M | -0.61% | 605,689 | 1.00 |
| 275 | NAGE | Niagen Bioscience, Inc. | 268.96M | -2.32% | 567,435 | 130.42M |
| 276 | SLGL | Sol-Gel Technologies Ltd. | 261.52M | 2.59% | 59,455 | 18.47M |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 254.85M | -2.19% | 507,365 | 26.87M |
| 278 | IMRX | Immuneering Corporation | 254.26M | -7.96% | 2,136,883 | - |
| 279 | IFRX | InflaRx N.V. | 251.87M | -7.07% | 1,171,971 | 33.82K |
| 280 | NVCT | Nuvectis Pharma, Inc. | 249.87M | -1.26% | 41,436 | - |
| 281 | ELTX | Elicio Therapeutics, Inc. | 249.27M | 2.19% | 84,684 | - |
| 282 | MGNX | MacroGenics, Inc. | 246.61M | -0.77% | 641,177 | 157.08M |
| 283 | AVXL | Anavex Life Sciences Corp. | 242.80M | 1.95% | 895,042 | - |
| 284 | SRZN | Surrozen, Inc. | 240.22M | -3.86% | 145,771 | 7.49M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 238.94M | 0.59% | 349,022 | 114.70K |
| 286 | INDP | Indaptus Therapeutics, Inc. | 237.81M | -42.62% | 1,422,901 | - |
| 287 | CDXS | Codexis, Inc. | 236.79M | 1.76% | 554,260 | 78.09M |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 236.53M | 1.28% | 104,457 | 32.72M |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 229.22M | -6.78% | 3,314,166 | 80.00M |
| 290 | TARA | Protara Therapeutics, Inc. | 227.07M | -2.88% | 730,505 | - |
| 291 | TRDA | Entrada Therapeutics, Inc. | 225.57M | -1.73% | 245,830 | 5.74M |
| 292 | FATE | Fate Therapeutics, Inc. | 222.63M | -3.54% | 1,368,512 | 6.32M |
| 293 | CHRS | Coherus Oncology, Inc. | 219.03M | -2.07% | 622,356 | 46.88M |
| 294 | CLLS | Cellectis S.A. | 218.98M | -4.25% | 53,346 | 75.11M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 217.83M | -0.54% | 129,667 | 28.22M |
| 296 | ACIU | AC Immune SA | 217.25M | -2.67% | 296,481 | 4.62M |
| 297 | NERV | Minerva Neurosciences, Inc. | 215.71M | -6.65% | 110,692 | - |
| 298 | ADAG | Adagene Inc. | 215.40M | -1.81% | 81,900 | 7.67M |
| 299 | CAMP | Camp4 Therapeutics Corporation | 212.38M | -0.49% | 77,821 | 3.93M |
| 300 | ALXO | ALX Oncology Holdings Inc. | 211.26M | 1.95% | 664,068 | - |
| 301 | LENZ | LENZ Therapeutics, Inc. | 210.70M | -4.14% | 303,289 | 20.99M |
| 302 | YDES | YD Bio Limited | 208.85M | -1.33% | 5,091 | 510.36K |
| 303 | QTTB | Q32 Bio Inc. | 203.99M | -8.24% | 660,129 | 53.74M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 203.62M | 1.20% | 448,912 | 36.49M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 202.37M | -2.47% | 334,562 | 54.71M |
| 306 | HELP | Cybin Inc. | 200.64M | -3.37% | 426,512 | - |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 198.80M | -3.13% | 366,949 | 7.15M |
| 308 | KROS | Keros Therapeutics, Inc. | 197.92M | -2.91% | 169,216 | 33.18M |
| 309 | RNA | Atrium Therapeutics, Inc. | 197.57M | -2.12% | 126,141 | 36.68M |
| 310 | NGEN | NervGen Pharma Corp. | 193.29M | -2.15% | 486,048 | - |
| 311 | CGEN | Compugen Ltd. | 192.95M | -2.86% | 458,934 | 72.66M |
| 312 | KPTI | Karyopharm Therapeutics Inc. | 191.69M | -6.39% | 260,094 | 151.12M |
| 313 | TNXP | Tonix Pharmaceuticals Holding Corp. | 186.67M | 5.78% | 471,237 | 17.56M |
| 314 | MDWD | MediWound Ltd. | 182.63M | 0.21% | 175,187 | 14.48M |
| 315 | CRBU | Caribou Biosciences, Inc. | 182.49M | -4.17% | 1,656,008 | 11.20M |
| 316 | ALEC | Alector, Inc. | 182.08M | 0.31% | 667,751 | 18.42M |
| 317 | NBP | NovaBridge Biosciences | 180.41M | -5.17% | 458,476 | - |
| 318 | UNCY | Unicycive Therapeutics, Inc. | 177.82M | -3.76% | 1,043,538 | - |
| 319 | OKUR | OnKure Therapeutics, Inc. | 177.74M | 5.01% | 320,194 | - |
| 320 | EQ | Equillium, Inc. | 175.14M | -5.78% | 666,461 | 4.39M |
| 321 | DTIL | Precision BioSciences, Inc. | 174.68M | 4.15% | 842,457 | 45.07M |
| 322 | ENLV | Enlivex Ltd. | 172.84M | 0.99% | 114,036 | - |
| 323 | RNAC | Cartesian Therapeutics, Inc. | 172.18M | 0.34% | 143,821 | 1.78M |
| 324 | NKTX | Nkarta, Inc. | 171.71M | -4.38% | 407,684 | - |
| 325 | IPHA | Innate Pharma S.A. | 167.94M | 2.92% | 13,301 | 10.57M |
| 326 | MIST | Milestone Pharmaceuticals Inc. | 167.34M | - | 1,485,677 | 1.78M |
| 327 | IMUX | Immunic, Inc. | 164.28M | -5.56% | 201,610 | - |
| 328 | PRQR | ProQR Therapeutics N.V. | 161.20M | 2.00% | 387,102 | 15.73M |
| 329 | TTRX | Turn Therapeutics Inc. | 158.77M | 0.95% | 21,909 | - |
| 330 | SPRO | Spero Therapeutics, Inc. | 158.65M | -2.84% | 649,202 | 61.19M |
| 331 | GALT | Galectin Therapeutics Inc. | 158.06M | 3.00% | 193,300 | - |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 157.92M | -1.51% | 454,563 | 76.38M |
| 333 | TLSA | Tiziana Life Sciences Ltd | 157.76M | -1.61% | 118,768 | - |
| 334 | CNTX | Context Therapeutics Inc. | 157.11M | -2.29% | 629,133 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 156.73M | 0.93% | 215,696 | - |
| 336 | NRXP | NRx Pharmaceuticals, Inc. | 156.73M | 4.59% | 1,844,689 | 2.29M |
| 337 | KRRO | Korro Bio, Inc. | 152.74M | -1.21% | 115,171 | 3.84M |
| 338 | CNTN | Canton Strategic Holdings, Inc. | 150.14M | 15.22% | 988,188 | - |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 148.97M | -1.89% | 135,160 | 2.00M |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 148.95M | -5.73% | 4,167,237 | 225.00K |
| 341 | MENS | Jyong Biotech Ltd. | 148.47M | -0.99% | 36,296 | - |
| 342 | MOLN | Molecular Partners AG | 147.78M | -3.66% | 6,146 | 856.30K |
| 343 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.07M | - | 219,421 | - |
| 344 | ANTX | AN2 Therapeutics, Inc. | 138.58M | 0.79% | 132,747 | - |
| 345 | CNTB | Connect Biopharma Holdings Limited | 138.52M | 1.38% | 203,534 | 233.00K |
| 346 | SPRB | Spruce Biosciences, Inc. | 135.74M | -2.20% | 31,276 | 697.00K |
| 347 | ACOG | Alpha Cognition Inc. | 131.08M | 3.44% | 10,113 | 10.83M |
| 348 | AGEN | Agenus Inc. | 130.43M | -2.79% | 367,658 | 123.87M |
| 349 | KZIA | Kazia Therapeutics Limited | 130.27M | 3.73% | 183,127 | 1.27M |
| 350 | HURA | TuHURA Biosciences, Inc. | 130.23M | 4.07% | 442,850 | - |
| 351 | GNLX | Genelux Corporation | 130.12M | - | 80,736 | 8.00K |
| 352 | ADCT | ADC Therapeutics SA | 124.35M | -5.08% | 12,492,750 | 79.18M |
| 353 | ALPS | Alps Group Inc | 119.39M | 1.06% | 10,488 | 3.74M |
| 354 | PLYX | Polaryx Therapeutics, Inc. | 116.46M | 5.58% | 104,280 | - |
| 355 | NTHI | NeOnc Technologies Holdings, Inc. | 113.67M | 1.58% | 66,561 | 39.99K |
| 356 | ENGN | enGene Therapeutics Inc. | 110.53M | 0.61% | 614,437 | - |
| 357 | CGTX | Cognition Therapeutics, Inc. | 108.12M | -6.20% | 826,011 | - |
| 358 | PYXS | Pyxis Oncology, Inc. | 107.07M | -5.06% | 162,540 | 13.86M |
| 359 | COYA | Coya Therapeutics, Inc. | 106.73M | 2.94% | 83,989 | 7.94M |
| 360 | GUTS | Fractyl Health, Inc. | 106.29M | -1.27% | 863,188 | 3.00K |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 106.01M | -6.09% | 1,114,102 | 70.00M |
| 362 | ALDX | Aldeyra Therapeutics, Inc. | 104.96M | 6.75% | 1,788,096 | - |
| 363 | VRCA | Verrica Pharmaceuticals Inc. | 102.90M | -0.83% | 37,707 | 37.16M |
| 364 | CRDF | Cardiff Oncology, Inc. | 102.55M | - | 854,920 | 525.00K |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 99.21M | -6.08% | 57,904 | - |
| 366 | VANI | Vivani Medical, Inc. | 99.17M | -2.54% | 131,810 | - |
| 367 | SEER | Seer, Inc. | 98.42M | - | 170,995 | 15.17M |
| 368 | ONCY | Oncolytics Biotech Inc. | 97.55M | 0.45% | 1,180,752 | - |
| 369 | FBIO | Fortress Biotech, Inc. | 94.67M | 7.55% | 982,379 | 66.16M |
| 370 | CUE | Cue Biopharma, Inc. | 94.67M | -1.29% | 47,328 | 32.73M |
| 371 | CBUS | Cibus, Inc. | 93.83M | -4.65% | 227,936 | 3.64M |
| 372 | PEPG | PepGen Inc. | 93.38M | -4.26% | 474,897 | - |
| 373 | PTHS | Pelthos Therapeutics Inc. | 91.41M | 2.94% | 1,845 | 27.70M |
| 374 | ICCC | ImmuCell Corporation | 89.36M | 2.78% | 6,002 | 29.93M |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 89.31M | 1.87% | 1,436,517 | 65.34K |
| 376 | PYPD | PolyPid Ltd. | 88.58M | 2.67% | 68,573 | - |
| 377 | RNTX | Rein Therapeutics Inc. | 88.27M | 0.59% | 453,213 | - |
| 378 | OTLK | Outlook Therapeutics, Inc. | 87.26M | -7.04% | 8,661,563 | 333.14K |
| 379 | PMN | ProMIS Neurosciences, Inc. | 87.08M | 6.35% | 12,620 | - |
| 380 | HRTX | Heron Therapeutics, Inc. | 85.86M | 6.13% | 2,595,787 | 150.71M |
| 381 | RLYB | Rallybio Corporation | 84.16M | -0.25% | 21,742 | 858.00K |
| 382 | OKYO | OKYO Pharma Limited | 83.97M | -1.23% | 22,756 | - |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 83.80M | 1.22% | 488,414 | 3.17M |
| 384 | BMEA | Biomea Fusion, Inc. | 83.14M | -9.45% | 2,283,639 | - |
| 385 | ANIX | Anixa Biosciences, Inc. | 82.48M | -0.81% | 122,236 | - |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 81.55M | -3.43% | 113,208 | 23.14M |
| 387 | LONA | LeonaBio, Inc. | 80.69M | 4.50% | 12,917 | - |
| 388 | OSTX | OS Therapies Incorporated | 79.72M | 0.56% | 494,788 | - |
| 389 | HYFT | MindWalk Holdings Corp. | 79.47M | -4.76% | 223,626 | 20.70M |
| 390 | CSBR | Champions Oncology, Inc. | 78.32M | -0.18% | 8,128 | 57.95M |
| 391 | AARD | Aardvark Therapeutics, Inc. | 78.32M | -2.45% | 108,329 | - |
| 392 | LIXT | Lixte Biotechnology Holdings, Inc. | 77.26M | -5.00% | 419,172 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 77.22M | -6.62% | 616,062 | - |
| 394 | NRXS | NeurAxis, Inc. | 76.74M | -2.49% | 97,098 | 4.28M |
| 395 | ANVS | Annovis Bio, Inc. | 76.15M | -5.29% | 931,332 | - |
| 396 | ACET | Adicet Bio, Inc. | 75.82M | -0.55% | 53,876 | - |
| 397 | EXOZ | eXoZymes, Inc. | 73.09M | -7.71% | 11,199 | -700.00 |
| 398 | XBIT | XBiotech Inc. | 72.26M | - | 23,171 | - |
| 399 | GANX | Gain Therapeutics, Inc. | 72.09M | -0.59% | 545,630 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 71.83M | 0.87% | 169,378 | - |
| 401 | ATHE | Alterity Therapeutics Limited | 70.35M | 0.51% | 8,967 | 4.43M |
| 402 | BYSI | BeyondSpring Inc. | 69.90M | -0.58% | 22,433 | 1.88M |
| 403 | FLNA | Filana Therapeutics, Inc. | 69.08M | 8.33% | 344,912 | - |
| 404 | TCRX | TScan Therapeutics, Inc. | 64.95M | 1.22% | 240,780 | 9.14M |
| 405 | MNOV | MediciNova, Inc. | 63.99M | -0.76% | 35,363 | 596.64K |
| 406 | IMA | ImageneBio, Inc. | 63.50M | -0.35% | 7,498 | 800.00K |
| 407 | IBIO | iBio, Inc. | 62.53M | -4.95% | 641,584 | 300.00K |
| 408 | MCRB | Seres Therapeutics, Inc. | 60.82M | -5.28% | 88,991 | 1.15M |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 60.35M | -1.40% | 195,665 | - |
| 410 | IBO | Impact BioMedical Inc. | 60.35M | -1.27% | 149,359 | 39.00K |
| 411 | CING | Cingulate Inc. | 60.14M | 0.78% | 207,730 | - |
| 412 | ENTX | Entera Bio Ltd. | 59.07M | 1.69% | 26,564 | 42.00K |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 58.13M | -2.68% | 185,265 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 56.49M | -4.47% | 21,376 | - |
| 415 | PDSB | PDS Biotechnology Corporation | 55.82M | -1.96% | 649,477 | - |
| 416 | TIL | Instil Bio, Inc. | 54.80M | 0.12% | 10,371 | - |
| 417 | RADX | Radiopharm Theranostics Limited | 50.12M | -2.55% | 16,681 | 10.86M |
| 418 | IMMP | Immutep Limited | 50.02M | -2.04% | 598,111 | 5.28M |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 48.77M | -2.67% | 48,775 | - |
| 420 | TVGN | Tevogen Bio Holdings Inc. | 48.74M | 11.17% | 14,532 | - |
| 421 | MREO | Mereo BioPharma Group plc | 48.68M | -2.62% | 2,453,860 | 500.00K |
| 422 | ESLA | Estrella Immunopharma, Inc. | 48.63M | -0.88% | 62,580 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 48.56M | 0.78% | 79,323 | 22.33M |
| 424 | VERU | Veru Inc. | 48.15M | -11.76% | 2,651,006 | 16.89M |
| 425 | LTRN | Lantern Pharma Inc. | 47.85M | 4.46% | 379,531 | - |
| 426 | EDSA | Edesa Biotech, Inc. | 47.72M | -1.65% | 303,350 | - |
| 427 | XLO | Xilio Therapeutics, Inc. | 45.95M | -0.26% | 22,149 | 53.48M |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 44.01M | 5.79% | 116,666 | - |
| 429 | ACTU | Actuate Therapeutics, Inc. | 43.55M | -3.19% | 66,992 | - |
| 430 | ATYR | aTyr Pharma, Inc. | 43.35M | -5.94% | 1,778,427 | 190.00K |
| 431 | NTRB | Nutriband Inc. | 42.91M | -1.40% | 15,211 | 2.04M |
| 432 | KALA | KALA BIO, Inc. | 42.57M | 11.17% | 232,812 | - |
| 433 | GNTA | Genenta Science S.p.A. | 42.46M | -11.76% | 423,030 | - |
| 434 | HYPD | Hyperion DeFi, Inc. | 41.62M | -2.01% | 740,732 | 1.04M |
| 435 | GRDX | GridAI Technologies Corp. | 41.38M | -2.05% | 40,923 | - |
| 436 | RNXT | RenovoRx, Inc. | 39.94M | 1.56% | 429,579 | 1.49M |
| 437 | ATOS | Atossa Therapeutics, Inc. | 39.18M | 1.79% | 35,993 | - |
| 438 | GOSS | Gossamer Bio, Inc. | 38.87M | -5.37% | 14,269,252 | 55.54M |
| 439 | PSTV | Plus Therapeutics, Inc. | 38.06M | 2.22% | 145,129 | 5.18M |
| 440 | GRCE | Grace Therapeutics, Inc. | 35.59M | - | 165,880 | - |
| 441 | ABVC | ABVC BioPharma, Inc. | 33.86M | 0.75% | 77,572 | 797.92K |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 33.05M | -1.85% | 158,874 | 90.00K |
| 443 | INMB | INmune Bio Inc. | 32.97M | -1.59% | 292,967 | 50.00K |
| 444 | NNVC | NanoViricides, Inc. | 32.58M | 3.62% | 505,467 | - |
| 445 | BOLD | Boundless Bio, Inc. | 32.06M | 0.70% | 70,992 | - |
| 446 | LSTA | Lisata Therapeutics, Inc. | 31.43M | 3.88% | 35,515 | 170.00K |
| 447 | EVAX | Evaxion A/S | 31.11M | 5.07% | 19,537 | 7.53M |
| 448 | APLM | Apollomics, Inc. | 30.74M | - | 10,291 | 8.84M |
| 449 | ALGS | Aligos Therapeutics, Inc. | 30.69M | 1.02% | 65,285 | 4.71M |
| 450 | IGC | IGC Pharma, Inc. | 29.54M | 4.55% | 630,623 | 1.11M |
| 451 | BRNS | Barinthus Biotherapeutics plc | 29.41M | 10.41% | 1,792,150 | 14.97M |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 29.33M | -2.47% | 106,851 | 38.00K |
| 453 | SER | Serina Therapeutics, Inc. | 28.31M | 1.06% | 60,733 | 130.00K |
| 454 | DARE | Daré Bioscience, Inc. | 27.71M | -1.60% | 171,645 | 1.16M |
| 455 | KYNB | Kyntra Bio, Inc. | 27.19M | 0.09% | 12,468 | 7.44M |
| 456 | SKYE | Skye Bioscience, Inc. | 27.05M | 5.02% | 133,837 | - |
| 457 | CRVO | CervoMed Inc. | 26.94M | -1.02% | 21,643 | 2.09M |
| 458 | TVRD | Tvardi Therapeutics, Inc. | 26.74M | -1.38% | 77,610 | - |
| 459 | BCTX | BriaCell Therapeutics Corp. | 26.69M | 0.32% | 91,574 | - |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 26.57M | 0.20% | 125,090 | - |
| 461 | QNTM | Quantum BioPharma Ltd. | 25.78M | -4.93% | 265,277 | - |
| 462 | LITS | Lite Strategy, Inc. | 25.69M | 0.81% | 361,679 | - |
| 463 | DYAI | Dyadic International, Inc. | 25.47M | -1.63% | 65,809 | 3.81M |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 25.24M | 4.01% | 64,435 | -13.27K |
| 465 | PLUR | Pluri Inc. | 24.92M | -2.12% | 6,682 | 1.08M |
| 466 | PTN | Palatin Technologies, Inc. | 24.64M | -0.21% | 1,581 | 12.88M |
| 467 | ALLR | Allarity Therapeutics, Inc. | 24.43M | -1.86% | 107,380 | 345.00K |
| 468 | MRKR | Marker Therapeutics, Inc. | 24.34M | 2.82% | 89,009 | 3.55M |
| 469 | CELU | Celularity Inc. | 23.50M | -6.92% | 183,594 | 26.55M |
| 470 | LGVN | Longeveron Inc. | 23.48M | 3.29% | 106,809 | 1.22M |
| 471 | PLRZ | Polyrizon Ltd. | 23.44M | -3.62% | 8,861 | - |
| 472 | VYNE | VYNE Therapeutics Inc. | 21.95M | 0.38% | 138,181 | 454.00K |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 21.28M | -1.23% | 520,201 | 789.00K |
| 474 | TRAW | Traws Pharma, Inc. | 20.76M | - | 184,962 | 2.73M |
| 475 | CLRB | Cellectar Biosciences, Inc. | 20.06M | -3.09% | 153,596 | - |
| 476 | CVM | CEL-SCI Corporation | 20.00M | 0.73% | 160,818 | - |
| 477 | KTTA | Pasithea Therapeutics Corp. | 19.23M | -1.61% | 240,931 | - |
| 478 | AEON | AEON Biopharma, Inc. | 19.20M | 1.10% | 7,089 | - |
| 479 | XCUR | Exicure, Inc. | 19.06M | 2.40% | 23,512 | 500.00K |
| 480 | CRIS | Curis, Inc. | 18.79M | -0.68% | 284,165 | 7.06M |
| 481 | HOWL | Werewolf Therapeutics, Inc. | 18.56M | -2.65% | 694,464 | 1.14M |
| 482 | TPST | Tempest Therapeutics, Inc. | 18.22M | - | 79,045 | - |
| 483 | AKTX | Akari Therapeutics, Plc | 17.68M | 2.49% | 21,118 | - |
| 484 | PASG | Passage Bio, Inc. | 17.55M | -2.67% | 28,880 | - |
| 485 | SNSE | Sensei Biotherapeutics, Inc. | 17.45M | -11.26% | 49,509 | - |
| 486 | NCEL | NewcelX Ltd. | 17.44M | 10.58% | 39,555 | - |
| 487 | LPCN | Lipocine Inc. | 16.37M | -0.49% | 95,847 | 2.00M |
| 488 | QNCX | Quince Therapeutics, Inc. | 16.30M | -0.99% | 247,275 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 16.18M | 5.21% | 472,615 | 5.61M |
| 490 | LEXX | Lexaria Bioscience Corp. | 16.03M | 1.51% | 19,091 | 368.00K |
| 491 | HIND | Vyome Holdings, Inc. | 15.37M | 1.39% | 63,888 | 152.72K |
| 492 | GTBP | GT Biopharma, Inc. | 15.33M | -2.57% | 1,297,133 | - |
| 493 | CALC | CalciMedica, Inc. | 15.08M | -9.62% | 564,907 | - |
| 494 | MLEC | Moolec Science SA | 14.85M | -4.42% | 10,414 | 7.83M |
| 495 | INAB | IN8bio, Inc. | 14.18M | -0.69% | 26,355 | - |
| 496 | OSRH | OSR Holdings, Inc. | 14.15M | 3.87% | 798,487 | 2.63M |
| 497 | COCP | Cocrystal Pharma, Inc. | 13.93M | 4.74% | 40,099 | 225.00K |
| 498 | GDTC | CytoMed Therapeutics Limited | 13.61M | -10.85% | 126,000 | 669.28K |
| 499 | BLRX | BioLineRx Ltd. | 13.41M | 0.62% | 12,984 | 1.40M |
| 500 | MBRX | Moleculin Biotech, Inc. | 13.18M | 2.92% | 181,651 | - |